Figure 1.

Bergamottin inhibits the migration of glioma cells. (A) Chemical structure of bergamottin. (B) Glioma cells in serum-free medium were treated with the indicated concentrations of bergamottin for 48 h and tested for cell viability. Quantitative data from three independent experiments are presented. (C) Cells were treated with different concentrations of bergamottin for 48 h and subjected to wound-healing assay. Images are representative from one experiment and were captured 48 h after scratching (magnification, ×40). The mean percentages (± standard error) of three independent experiments performed with two replicates are presented. *P<0.05 vs. untreated cells; ^#P<0.05 vs. 2 µM bergamottin. NS, no significance when compared with control cells.